Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Interaction between the microbiome and TP53 in human lung cancer

Open access

Abstract

Background: Lung cancer is the leading cancer diagnosis worldwide and the number one cause of cancer deaths. Exposure to cigarette smoke, the primary risk factor in lung cancer, reduces epithelial barrier integrity and increases susceptibility to infections. Herein, we hypothesize that somatic mutations together with cigarette smoke generate a dysbiotic microbiota that is associated with lung carcinogenesis. Using lung tissue from 33 controls and 143 cancer cases, we conduct 16S ribosomal RNA (rRNA) bacterial gene sequencing, with RNA-sequencing data from lung cancer cases in The Cancer Genome Atlas serving as the validation cohort. Results: Overall, we demonstrate a lower alpha diversity in normal lung as compared to non-tumor adjacent or tumor tissue. In squamous cell carcinoma specifically, a separate group of taxa are identified, in which Acidovorax is enriched in smokers. Acidovorax temporans is identified within tumor sections by fluorescent in situ hybridization and confirmed by two separate 16S rRNA strategies. Further, these taxa, including Acidovorax , exhibit higher abundance among the subset of squamous cell carcinoma cases with TP53 mutations, an association not seen in adenocarcinomas. Conclusions: The results of this comprehensive study show both microbiome-gene and microbiome-exposure interactions in squamous cell carcinoma lung cancer tissue. Specifically, tumors harboring TP53 mutations, which can impair epithelial function, have a unique bacterial consortium that is higher in relative abundance in smoking-associated tumors of this type. Given the significant need for clinical diagnostic tools in lung cancer, this study may provide novel biomarkers for early detection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13059-018-1501-6

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 The bacterial profile and diversity of the lung microbiome in non-diseased and cancerous tissues. a 16S rRNA gene sequences from non-diseased lung (ImA or HB; top), non-tumor adjacent (NT) and tumor (T) assigned to OTUs or proportional abundance of metatranscriptomic sequences (TCGA; bottom) at the phylum level showing the most dominant taxa for each tissue type. b Alpha diversity between non-diseased lung tissue (ImA and HB) non-tumor adjacent (NT) and tumors from 16S rRNA gene sequencing using Chao1 (richness) or inverse Simpson index. *p < 0.05, **p < 0.01. Test of significance is Mann–Whitney. PCoA plots from NCI-MD study of tissue microbiome beta-diversity colored by (c) all tissue types, (d) cancer cases, and (e) histological subtype; and from TCGA study of (f) cancer cases and (g) histological subtype. ImA immediate autopsy, HB hospital biopsy
Fig. 1 The bacterial profile and diversity of the lung microbiome in non-diseased and cancerous tissues. a 16S rRNA gene sequences from non-diseased lung (ImA or HB; top), non-tumor adjacent (NT) and tumor (T) assigned to OTUs or proportional abundance of metatranscriptomic sequences (TCGA; bottom) at the phylum level showing the most dominant taxa for each tissue type. b Alpha diversity between non-diseased lung tissue (ImA and HB) non-tumor adjacent (NT) and tumors from 16S rRNA gene sequencing using Chao1 (richness) or inverse Simpson index. *p < 0.05, **p < 0.01. Test of significance is Mann–Whitney. PCoA plots from NCI-MD study of tissue microbiome beta-diversity colored by (c) all tissue types, (d) cancer cases, and (e) histological subtype; and from TCGA study of (f) cancer cases and (g) histological subtype. ImA immediate autopsy, HB hospital biopsyCC BY · PubMed Central
Fig. 2 Taxonomic consortia differentiating smoking status and histological subtype of lung cancer. a Heat maps showing top differentially abundant genera (NCI-MD) (Mann–Whitney p value < 0.05; * overlapping between NCI-MD and TCGA) between AD and SCC lung cancer tissue sorted by histological subtype and smoking status. b Heat map showing genera (TCGA) that that are differentially abundant between AD and SCC (Mann–Whitney FDR corrected p < 0.05), sorted by histological subtype and smoking. c Forest plot of odds ratios for genera in NCI-MD dataset that are significantly associated with SCC compared to AD in tumors (adjusted odds ratio p < 0.05). d Forest plot of odds ratios for species in the TCGA dataset that are significantly associated with SCC vs AD in tumors (adjusted odds ratio FDR corrected p < 0.05)
Fig. 2 Taxonomic consortia differentiating smoking status and histological subtype of lung cancer. a Heat maps showing top differentially abundant genera (NCI-MD) (Mann–Whitney p value < 0.05; * overlapping between NCI-MD and TCGA) between AD and SCC lung cancer tissue sorted by histological subtype and smoking status. b Heat map showing genera (TCGA) that that are differentially abundant between AD and SCC (Mann–Whitney FDR corrected p < 0.05), sorted by histological subtype and smoking. c Forest plot of odds ratios for genera in NCI-MD dataset that are significantly associated with SCC compared to AD in tumors (adjusted odds ratio p < 0.05). d Forest plot of odds ratios for species in the TCGA dataset that are significantly associated with SCC vs AD in tumors (adjusted odds ratio FDR corrected p < 0.05)CC BY · PubMed Central
Fig. 3 Relative abundance of Acidovorax stratified by smoking status and histological subtype. a Relative abundance of Acidovorax stratified by smoking status in the NCI-MD (left) and TCGA (right) datasets. b Relative abundance of Acidovorax in never, former, and current smokers stratified by histological subtype in the NCI-MD (left) and TCGA (right) datasets. c Representative FISH images of tumor tissue sections using fluorescent probe specific to Acidovorax. d Quantification of Acidovorax probe reactivity (10 fields; at least 300 cells counted) showing percentage (%) of cells with perinuclear probe reactivity from two lung cancer cases (15,713 – SCC/current smoker; 20,172 – SCC/former smoker). *p < 0.05, **p < 0.01, ****p < 0.0001. Tests of significance are Mann–Whitney or Kruskal–Wallis and Dunn’s multiple comparisons test. NS non-significant
Fig. 3 Relative abundance of Acidovorax stratified by smoking status and histological subtype. a Relative abundance of Acidovorax stratified by smoking status in the NCI-MD (left) and TCGA (right) datasets. b Relative abundance of Acidovorax in never, former, and current smokers stratified by histological subtype in the NCI-MD (left) and TCGA (right) datasets. c Representative FISH images of tumor tissue sections using fluorescent probe specific to Acidovorax. d Quantification of Acidovorax probe reactivity (10 fields; at least 300 cells counted) showing percentage (%) of cells with perinuclear probe reactivity from two lung cancer cases (15,713 – SCC/current smoker; 20,172 – SCC/former smoker). *p < 0.05, **p < 0.01, ****p < 0.0001. Tests of significance are Mann–Whitney or Kruskal–Wallis and Dunn’s multiple comparisons test. NS non-significantCC BY · PubMed Central
Fig. 4 Mutations in TP53 associated with abundance of taxonomic signature specific to squamous cell lung tumors. a Heat map of genus-level abundance in NCI-MD data colored by mutation status, TP53 wild-type or mutated, smoking, and histological subtype in all lung tumor samples. b Heat map of genus-level abundance from TCGA data in all tumors colored by mutation status, TP53 wild-type or mutated, smoking, and histological subtype. c, d Fold change in mean abundance of SCC-associated taxa in NCI-MD or TCGA tissues comparing TP53 mutated to wild-type. Test of significance is Mann–Whitney. Fold change among all taxa in (d) are significant after FDR correction < 0.01. (NCI-MD; SCCwt = 11, SCCmut = 35 and TCGA; SCCwt = 59, SCCmut = 118)
Fig. 4 Mutations in TP53 associated with abundance of taxonomic signature specific to squamous cell lung tumors. a Heat map of genus-level abundance in NCI-MD data colored by mutation status, TP53 wild-type or mutated, smoking, and histological subtype in all lung tumor samples. b Heat map of genus-level abundance from TCGA data in all tumors colored by mutation status, TP53 wild-type or mutated, smoking, and histological subtype. c, d Fold change in mean abundance of SCC-associated taxa in NCI-MD or TCGA tissues comparing TP53 mutated to wild-type. Test of significance is Mann–Whitney. Fold change among all taxa in (d) are significant after FDR correction < 0.01. (NCI-MD; SCCwt = 11, SCCmut = 35 and TCGA; SCCwt = 59, SCCmut = 118)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Research works printed but not linked: 1

  1. Sequence read archive. http://www.ncbi.nlm.nih.gov/bioproject/320383 .

Cited by

See all 495

Metadata

Authors
Greathouse, K. L., White, J. R., Vargas, A. J., Bliskovsky, V. V., Beck, J. A., von Muhlinen, N., Polley, E. C., Bowman, E. D., Khan, M. A., Robles, A. I., Cooks, T., Ryan, B. M., Padgett, N., Dzutsev, A. H., Trinchieri, G., Pineda, M. A., Bilke, S., Meltzer, P. S., Hokenstad, A. N., Stickrod, T. M., Walther-Antonio, M. R., Earl, J. P., Mell, J. C., Krol, J. E., Balashov, S. V., Bhat, A. S., Ehrlich, G. D., Valm, A., Deming, C., Conlan, S., Oh, J., Segre, J. A., & Harris, C. C.
Affiliations
  • National Institutes of Health (US)
  • Resphera Biosciences (US)
  • Mayo Clinic (US)
  • Drexel University (US)
  • Jackson Laboratory (US)
Corresponding author
Harris, Curtis C.
Venue
Genome Biology
Published
2018-08-24
Volume
19
Issue
1
Pages
123-123
ISSN
  • 1465-6906 (ISSN-L)
  • 1474-760X
OpenAlex
W2888696120
Cited by
446
References
55
Citations by year
2026: 39 · 2025: 83 · 2024: 70 · 2023: 68 · 2022: 72 · 2021: 56 · 2020: 41 · 2019: 16
FWCI
10.05
Type
journal article
Language
en
Open access
Licence
Locations
  • Genome biology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion, cc-by)
Funders
National Cancer Institute (Intramural)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Keywords
lung cancer, microbiome, TP53 mutation, squamous cell carcinoma, cigarette smoking, bacterial dysbiosis, lung carcinogenesis, epithelial barrier integrity, lung adenocarcinoma, alpha diversity, early diagnosis biomarkers
MeSH terms
Smokers, Adult, Aged, Female, Humans, Lung Neoplasms, Male, Middle Aged, Mutation, Reproducibility of Results, Tumor Suppressor Protein p53, Neoplasms, Squamous Cell, Proteobacteria, Comamonadaceae, Biodiversity, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interaction between the microbiome and TP53 in human lung cancer. https://app.cochat.ai/papers/10.1186/s13059-018-1501-6
The paper
Greathouse, K. L., White, J. R., Vargas, A. J., Bliskovsky, V. V., Beck, J. A., von Muhlinen, N., Polley, E. C., Bowman, E. D., Khan, M. A., Robles, A. I., Cooks, T., Ryan, B. M., Padgett, N., Dzutsev, A. H., Trinchieri, G., Pineda, M. A., Bilke, S., Meltzer, P. S., Hokenstad, A. N., . . . Harris, C. C. (2018). Interaction between the microbiome and TP53 in human lung cancer. Genome Biology. https://doi.org/10.1186/s13059-018-1501-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.